Financial News
Latest News about MRK
Recent news which mentions MRK
5 Stocks To Watch For September 28, 2021
September 28, 2021
From Benzinga
Merck nears deal for rare-disease-drug maker Acceleron
September 28, 2021
From MarketWatch
Pfizer Begins Late-Stage Study To Test Effectiveness Of Oral Drug Against COVID-19 In Those Exposed To The Virus
September 28, 2021
From Benzinga
Merck's Keytruda Tops Placebo On Overall Survival Endpoint In Liver Cancer Patients
September 27, 2021
Tickers
MRK
From Benzinga
Acceleron In Advanced $11B Buyout Talks: Bloomberg
September 27, 2021
From Benzinga
Why AstraZeneca Stock Is Trading Higher Today
September 24, 2021
From Benzinga
AstraZeneca - Merck's Lynparza Delays Disease Progression In Prostate Cancer Patients
September 24, 2021
From Benzinga
9 Health Care Stocks Showing Unusual Options Activity In Today's Session
September 21, 2021
From Benzinga
These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond
September 21, 2021
From Motley Fool
Apple And Disney Lead The Dow Jones Lower
September 20, 2021
From Benzinga
Here are the worst-performing U.S. stocks as the Evergrande crisis rattles investors
September 20, 2021
From MarketWatch
Seagen, Genmab Present Tisotumab Vedotin Combo Data In Cervical Cancer
September 20, 2021
From Benzinga
How Moderna Stock Can Double From Here
September 20, 2021
From Motley Fool
Could Pfizer and Merck Be Big Winners With COVID Pills?
September 19, 2021
From Motley Fool
Barron's Latest Picks And Pans: Apple, Bitcoin, a Goldman Sachs ETF, Nike And More
September 18, 2021
From Benzinga
Athenex Shares Are Trading Higher On Positive Oral Paclitaxel Data From Solid Tumor Trial
September 16, 2021
From Benzinga
From Benzinga
Silverback Therapeutics Presents Initial Safety Data From Solid Tumor Combo Therapy Trial
September 16, 2021
From Benzinga
Is AbbVie's 4.9% Dividend Yield Safe?
September 15, 2021
From Motley Fool
Hookipa Pharma, Merck Team Up For Phase 2 Head & Neck Cancer Trial
September 15, 2021
From Benzinga
2 Best Biotech Stocks to Buy in September
September 15, 2021
From Motley Fool
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
From Benzinga
3 No-Brainer Warren Buffett Stocks to Buy Right Now
September 14, 2021
From Motley Fool
Why Are Silverback Therapeutics Shares Falling On Monday?
September 13, 2021
From Benzinga
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
September 12, 2021
From Benzinga
3 Dow Jones Stocks to Buy Hand Over Fist Right Now
September 12, 2021
From Motley Fool
How Keytruda's Latest Approval in China Boosts Merck
September 11, 2021
From Motley Fool
3 Smartest Big Pharma Stocks to Buy in September
September 11, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
